Coleman, R. J. and Lange, Klaus W. and Quinn, N. P. and Loper, A. E. and Bondi, J. V. and Hichens, M. and Stahl, S. M. and Marsden, C. D.
The antiparkinsonian actions and pharmacokinetics of transdermal (+)-4-propyl-9-hydroxynaphthoxazine (+PHNO): preliminary results.
Movement disorders 4 (2), pp. 129-138.
at publisher (via DOI)
(+)-4-Propyl-9-hydroxynaphthoxazine (+PHNO) is a potent dopamine agonist that has been administered transdermally to four patients with Parkinson's disease and "on-off" fluctuations. Skin patches of increasing size were used to treat these patients, who also received infrequent doses of oral levodopa if required. The effect of +PHNO was measured as an increased duration of action of individual ...
Export bibliographical data